COVID-19 Updates

COVID-related Charges on Sponsored Projects

PPE for returning to campus/lab work

PPE needed to return to campus/lab situations cannot be purchased on the grant unless the item was required under the original scope of work prior to the work at home declaration.

Replenishment of PPE donated from sponsored projects

NSF Implementation of Donated PPE

• Email sent from OSPA to current NSF PIs to identify PPE so we can notify NSF

NIH Implementation of Donated PPE

• Recipients may request prior approval from NIH to donate PPE and other lab supplies to hospitals, medical centers, and other local entities that are directly serving the public health emergency crisis for COVID-19 response. The guidance originally provided in OMB Memo M-20-20 has ended, effective June 16, 2020. NIH will consider future requests on a case by case basis.
• In order to proceed with these donations, recipients must maintain documentation that supports the following:
  • The donated equipment or supplies are not currently needed due to temporary suspension of project activities or no longer necessary to meet the objectives of the grant;
  • If the equipment remains in usable condition, it should be returned to its original purpose upon completion of the public health emergency;
  • The donations(s) will be documented for single audits ad will be provided to NIH funding ICs upon request;
  • As outlined in the NIH GPS (section 8.3.3.2.1) the title for equipment and supplies acquired under NIH grants vests with the recipient institution.
• Recipients should not assume that NIH funding ICs will provide additional funds to replace the donated PPE and supplies.

Unused travel credits  https://www.uky.edu/ufs/travel-services

• Refunds for airfare purchased on sponsored projects must be applied to the account where the expense originated
• “Unused ticket credit” refers to a full ticket credit, and “ticket credit” could refer to a partial credit, residual credit, or a credit voucher. 
• If unused ticket credits for cancelled airfare purchased on a sponsored project will not be utilized for that sponsored project, the originating airfare expense must be removed.
• Charge for travel must be placed on sponsored account corresponding to when the credit is used
• Same budget period –may need to move expense off sponsored project and transfer to sponsored project for new budget year if that is when travel occurs
• Non-refundable costs associated with grant-related travel that was cancelled due to COVID-19 may be an allowable expense to federally-sponsored if the costs would have otherwise been allowable and were incurred on or before June 16, 2020. Please refer to agency guidelines for applicability to a specific award

• COVID-19 Expense Tracking information from UK Purchasing

• NOT-OD-20-122: Guidance for Applicants Preparing Applications for the Fall 2020 Due Dates During the COVID-19 Pandemic dated July 8, 2020.
• FAQs on COVID-19  Flexibilities for Applicants and Recipients updated July 2, 2020.
• NIH Implementation of OMB Memorandum M-20-26 “Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations” dated June 18, 2020.
• NOT-OD-20-123 Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic dated June 9, 2020.
• Notice of NICHD Participation in NOT-EB-20-012 "Notice of Change in Application Due Date for PAR-19-215 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19) dated June 5, 2020.
• NIH Late Application Policy for Institutional Training Grants to PA-20-142 and PA-20-162 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19) dated May 11, 2020.
• OHRP Guidance on Response to COVID-19 dated April 28, 2020.
• Considerations for New and Ongoing Human Subjects Research During the COVID-19 Public Health Emergency dated April 24, 2020.
• COVID-19 Pandemic Response Resources and FAQs for Animal Care and Use Programs  dated April 8, 2020.
• Flexibilities Available to AHRQ Recipients and Applicants Directly Impacted by the Novel Coronavirus (COVID-19) Due to Loss of Operations dated April 6, 2020.
• UPDATE: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) - NOT-OD-20-091 dated March 26, 2020.
• Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19 - NOT-OD-20-087 dated March 16, 2020
• Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 - NOT-OD-20-086 dated March 12, 2020.
• General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19 - NOT-OD-20-083 dated March 10, 2020.
• NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) - NOT-OD-20-082 dated March 9, 2020.
• Based on NIH Guidance on Travel and Meetings dated March 9, 2020, in-person NIH peer review meetings are being held in alternate formats. Scientific review officers will be in contact with peer reviewers about these changes.
• COVID-19 Flexibilities for Applicants and Recipient FAQs 

For complete NIH information related to COVID-19, please see NIH Website: Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients and General Information on NIH Extramural Response to Natural Disasters and Other Emergencies.

• NSF Implementation of OMB Memorandum M-20-26 dated June 25, 2020.
• Impact on Existing Deadline Dates dated June 23, 2020.
• Frequently Asked Questions (FAQs) regarding the NSF Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) (NSF 20-052) Updated May 29, 2020.
• Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Proposers and Awardees dated May 19, 2020.
• Guidance on NSF's Implementation of OMB Memorandum M-20-17 updated May 19, 2020.
• NSF Guidance on the Effects of COVID-19 on Vertebrate Animal Research dated April 10, 2020.
• NSF NSF Implementation of OMB Memorandum M-20-20 entitled, “Repurposing Existing Federal Financial Assistance Programs and Awards to Support the Emergency Response to the Novel Coronavirus (COVID-19)” dated April 9, 2020.
• NSF Guidance on the Effects of COVID-19 on Human Subjects Research dated April 8, 2020.
• NSF 20-052, Dear Colleague Letter on the Coronavirus Disease 2019 dated on April 3, 2020.
• Important Notice No 146 dated March 23, 2020.
• NSF issued a Statement on Coronavirus Disease 2019 dated March 9, 2020. 

For complete NSF information related to COVID-19, please see Information from NSF on Coronavirus.

• ARPA-E Guidance for Non-Productive Labor Charges Attributable to the COVID-19 Public Health Emergency dated June 22, 2020.
• ARPA-E Actions Owing to the COVID-19 Public Health Emergency dated April 3, 2020.
• PF 2020-20 COVID-19 Guidance for Financial Assistance Actions dated March 30, 2020.
• Memorandum for Applicants and Awardees dated March 13, 2020.
• ARPA Funding Agreements and Project Guidance

For complete DOE information related to COVID-19, please see Coronavirus Hub.

• NIFA-20-005 NIFA Coronavirus FAQs dated April 23, 2020.

• NIFA-20-006 Implementation of OMB Memo M-20-17 dated April 16, 2020.
• NIFA Deadline extensions due to COVID-19 dated March 18, 2020.

For complete USDA information regarding COVID-19, please see Coronavirus Disease (COVID-19) FAQs.

For complete Fermilab information regarding COVID-19, please see Coronavirus (COVID-19) – Fermilab information.

• USAMRAA Animal Research Guidance dated March 19, 2020.
• FAQs on COVID-19's Impact to Human Subjects Research

COVID-19 FAQs for Grant Applicants and Recipients updated March 25, 2020.

For complete ANL information regarding COVID-19, please see Coronavirus Updates.

• COVID-19 Information for SAMHSA Discretionary Grant Recipients dated March 24, 2020.

For complete SAMHSA information regarding COVID-19, please see Coronavirus (COVID-19).

For complete HRSA information regarding COVID-19, please see COVID-19 Grantee Frequently Asked Questions dated March 2020.

• NEA FAQs and Information for Applicants and Grantees in response to COVID-19 dated March 31, 2020.
• Message from Chairman Mary Anne Carter

• FAQs – Funding for NEH Applicants and Grantees Impacted by the Coronavirus (undated)

For complete NEH information regarding COVID-19, please see Information on NEH and COVID-19.

National Institute of Justice

• Important Notices

Office of Community Oriented Policing Services

• COVID-19 Notice to Grantees dated March 21, 2020.

Office of Justice Programs

• FY 2020 Coronavirus Emergency Supplemental Funding Program; deadline: 5/29/2020 dated March 30, 2020.
• Grantee Update #2: Guidance on Short Term Administrative Relief for Grantees Impacted by COVID-19 dated March 21, 2020.
• OJP Grantee Update #1 COVID-19 Impacts dated March 16, 2020.

Office of Violence Against Women

• COVID-19 Update for Grantees - Updated Guidance on Short-Term Administrative Relief for Grantees Impacted by COVID-19 dated June 29, 2020.
• COVID-19 Update for Grantees - Resource Guide for Grantees dated April 30, 2020.
• COVID-19 Update for Grantees - Additional Flexibilities for the STOP Formula Program dated March 27, 2020.
• COVID-19 Update for Grantees - Guidance to Award Recipients Impacted by COVID-19: Short-term Relief for Various Administrative, Financial Management, and Audit Requirements dated March 26, 2020.
• COVID-19 Update for Grantees - FAQs for OVW Grantees Regarding the Payment and Use of Leave for Grant-Funded Staff dated March 19, 2020.
• COVID-19 Update for Grantees - Message from the OVW Acting Director dated March 19, 2020.
• COVID-19 Update for Grantees - Message from the OVW Acting Director dated March 17, 2020.

For complete DOJ information regarding COVID-19, please see Administrative Relief for DOJ Grant Recipients and Applicants Impacted by the Novel Coronavirus (COVID-19).

• ONR FAQs for Contracts and Other Transactions dated May 7, 2020.
• ONR FAQs to Current and Prospective Awardees Impacted by COVID-19 dated April 23, 2020.
• Information from ONR Regional Offices to Support Electronic Payments Refunds and Reporting

For complete ONR information regarding COVID-19, please see Coronavirus Assistance and Acquisition-Related Information and Resources.

• Health and Safety Information for Financial Assistance Recipients during COVID-19 dated March 27, 2020.

• Information for CDC Applicants and Recipients of CDC Funding dated March 23, 2020.
• Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 dated March 23, 2020.
• General Funding and Grants Frequently Asked Questions dated March 23, 2020.

For complete CDC information regarding COVID-19, please see Coronavirus Disease 2019 (COVID-19): Information for CDC Applicants and Recipients of CDC Funding.

• Message to Contractors on Health and Safety Precautions for COVID-19  dated March 24, 2020.

• NASA COVID -19 For Grantees
• NASA Implementation of OMB Memorandum M-20-17 (Undated) 
• Grants and Research during the COVID-19 Epidemic dated March 25, 2020.
• Memo to Contractors (Guidance Sent to Contractors, Subject to Change, 3/24/20)
• COVID-19 Impact to NASA SBIR/STTR Program dated March 20, 2020.
• Assistant Administrator for Procurement Message on Coronavirus dated March 10, 2020.

• ALLOW EXEMPTIONS FOR DOD FINANCIAL ASSISTANCE RECIPIENTS AFFECTED BY THE LOSS OF OPERATIONAL CAPACITY AND INCREASED COSTS DUE TO THE COVID-19 CRISIS
• COVID-19 FAQs for Grant Applicants and Recipients dated March 26, 2020.
• Frequently Asked Questions for DOD Research Proposers and Awardees Impacted by the Novel Coronavirus (COVID-19) dated March 24, 2020.

• FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic updated June 3, 2020. 
• FAQs on 3D Printing of Medical Devices, Accessories, Components, and Parts During the COVID-19 Pandemic
• FDA - Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 dated March 26, 2020. 

• OHRP Issues Guidance for Application of the Human Subjects Protection Regulations to Actions Taken in Response to the COVID-19 Pandemic dated April 9, 2020.
• OHRP Guidance on COVID-19 dated April 8, 2020. 
• Preparation for Potential COVID-19 Impact on Contract and Contractor Performance dated March 14, 2020. 
• Administration for Children and Families (ACF) Grantees and Recipients- Information Memorandum: IM-ACF-OA-2020-01 dated March 31, 2020.
• ORI Operations Status during Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)

• Guidance on No Cost Extensions  dated March 26, 2020. 
• Potential Contract Impacts due to Coronavirus (COVID-19) dated March 17, 2020.

• Memorandum authorizing COVID 19 flexibilities pursuant to OMB Memorandum M-20-17 dated March 27, 2020.
• INFORMATION FROM THE OFFICE OF ACQUISITION AND ASSISTANCE IN THE BUREAU FOR MANAGEMENT OF THE U.S. AGENCY FOR INTERNATIONAL DEVELOPMENT dated March 12, 2020.

• EPA Frequent Questions on Grant Issues in Response to the Novel Coronavirus (COVID-19) Public Health Emergency dated March 27, 2020.

Information for IMLS Grant Applicants and Awardees 

• Coronavirus (COVID-19) Response:  https://www.fema.gov/coronavirus
• Bringing Resources to State, Local, Tribal & Territorial Governments:  https://www.fema.gov/coronavirus/governments
• COVID-19 Fact Sheets & Guidance:  https://www.fema.gov/coronavirus/fact-sheets

• FREQUENTLY ASKED QUESTIONS (FAQS) ABOUT THE CORONAVIRUS DISEASE 2019 (COVID-19) FOR IES GRANTEES